構造的心疾患、β3アドレナリン受容体作動薬「Mirabegron」の応用について調べた研究「Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease The Beta3-LVH Phase 2b Randomized Clinical Trial
https://jamanetwork.com/journals/jamacardiology/fullarticle/2809846
https://medical-tribune.co.jp/news/2023/1013558639/index.html
構造的心疾患、β3アドレナリン受容体作動薬「Mirabegron」の応用について調べた研究「Repurposing the β3-Adrenergic Receptor Agonist Mirabegron in Patients With Structural Cardiac Disease The Beta3-LVH Phase 2b Randomized Clinical Trial